Skip to main content
Premium Trial:

Request an Annual Quote

Bradley Cole

Castle Biosciences has appointed Bradley Cole to its board of directors. Cole currently serves as Genomic Health's CFO. In addition, Cole served as both chief operating officer and CFO at the firm. Previously, Cole served as VP of finance and business development for the Endovascular Solutions Group at Guidant. Prior to that, he served as VP and general manager of the vascular surgery business unit of Guidant. Previously, he served as CFO at Endovascular Technologies until it was acquired by Guidant in 1997. Before Endovascular, he served as CFO at Applied Biosystems until 1994. 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.